Literature DB >> 20951748

Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system.

Shalmali Bivalkar-Mehla1, Janaki Vakharia, Rajeev Mehla, Measho Abreha, Jagat Rakesh Kanwar, Akshay Tikoo, Ashok Chauhan.   

Abstract

Pathogenic viruses have developed a molecular defense arsenal for their survival by counteracting the host anti-viral system known as RNA interference (RNAi). Cellular RNAi, in addition to regulating gene expression through microRNAs, also serves as a barrier against invasive foreign nucleic acids. RNAi is conserved across the biological species, including plants, animals and invertebrates. Viruses in turn, have evolved mechanisms that can counteract this anti-viral defense of the host. Recent studies of mammalian viruses exhibiting RNA silencing suppressor (RSS) activity have further advanced our understanding of RNAi in terms of host-virus interactions. Viral proteins and non-coding viral RNAs can inhibit the RNAi (miRNA/siRNA) pathway through different mechanisms. Mammalian viruses having dsRNA-binding regions and GW/WG motifs appear to have a high chance of conferring RSS activity. Although, RSSs of plant and invertebrate viruses have been well characterized, mammalian viral RSSs still need in-depth investigations to present the concrete evidences supporting their RNAi ablation characteristics. The information presented in this review together with any perspective research should help to predict and identify the RSS activity-endowed new viral proteins that could be the potential targets for designing novel anti-viral therapeutics.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20951748      PMCID: PMC3042272          DOI: 10.1016/j.virusres.2010.10.003

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  92 in total

1.  Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine.

Authors:  R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms.

Authors:  Yan Zeng; Rui Yi; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

3.  A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus.

Authors:  Amy L Hartman; Jonathan S Towner; Stuart T Nichol
Journal:  Virology       Date:  2004-10-25       Impact factor: 3.616

4.  The double-stranded RNA binding domain of the vaccinia virus E3L protein inhibits both RNA- and DNA-induced activation of interferon beta.

Authors:  Jean-Baptiste Marq; Stéphane Hausmann; Jeremy Luban; Daniel Kolakofsky; Dominique Garcin
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

5.  A region of basic amino-acid cluster in HIV-1 Tat protein is essential for trans-acting activity and nucleolar localization.

Authors:  S Endo; S Kubota; H Siomi; A Adachi; S Oroszlan; M Maki; M Hatanaka
Journal:  Virus Genes       Date:  1989-11       Impact factor: 2.332

6.  Dicer is involved in protection against influenza A virus infection.

Authors:  Alexey A Matskevich; Karin Moelling
Journal:  J Gen Virol       Date:  2007-10       Impact factor: 3.891

7.  Molecular cloning and sequencing of the La Crosse virus S RNA.

Authors:  C D Cabradilla; B P Holloway; J F Obijeski
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

8.  Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus.

Authors:  Jingmin Ji; Andrea Glaser; Marion Wernli; Jan Martin Berke; Darius Moradpour; Peter Erb
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

9.  La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts.

Authors:  Gjon Blakqori; Sophie Delhaye; Matthias Habjan; Carol D Blair; Irma Sánchez-Vargas; Ken E Olson; Ghassem Attarzadeh-Yazdi; Rennos Fragkoudis; Alain Kohl; Ulrich Kalinke; Siegfried Weiss; Thomas Michiels; Peter Staeheli; Friedemann Weber
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

Review 10.  What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?

Authors:  Grant R Campbell; Erwann P Loret
Journal:  Retrovirology       Date:  2009-05-25       Impact factor: 4.602

View more
  52 in total

1.  HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.

Authors:  Sylvanne M Daniels; Lucile Sinck; Natalie J Ward; Carlos E Melendez-Peña; Robert J Scarborough; Ibrahim Azar; Elodie Rance; Aïcha Daher; Ka-Ming Pang; John J Rossi; Anne Gatignol
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 2.  Epigenetic regulation in plants.

Authors:  Craig S Pikaard; Ortrun Mittelsten Scheid
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-12-01       Impact factor: 10.005

3.  Key importance of small RNA binding for the activity of a glycine-tryptophan (GW) motif-containing viral suppressor of RNA silencing.

Authors:  Miryam Pérez-Cañamás; Carmen Hernández
Journal:  J Biol Chem       Date:  2014-12-10       Impact factor: 5.157

4.  Pigmy MicroRNA: surveillance cops in Therapies kingdom.

Authors:  Utpal Bhadra; Pradipta Patra; Jagamohan Chhatai; Manika Pal-Bhadra
Journal:  Mol Med       Date:  2016-09-28       Impact factor: 6.354

Review 5.  Mammalian alphaherpesvirus miRNAs.

Authors:  Igor Jurak; Anthony Griffiths; Donald M Coen
Journal:  Biochim Biophys Acta       Date:  2011-06-28

Review 6.  MicroRNAs and HIV-1: complex interactions.

Authors:  Zachary Klase; Laurent Houzet; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

7.  Single cell analysis of RNA-mediated histone H3.3 recruitment to a cytomegalovirus promoter-regulated transcription site.

Authors:  Alyshia Newhart; Ilona U Rafalska-Metcalf; Tian Yang; Lucy M Joo; Sara Lawrence Powers; Andrew V Kossenkov; Melissa Lopez-Jones; Robert H Singer; Louise C Showe; Emmanuel Skordalakes; Susan M Janicki
Journal:  J Biol Chem       Date:  2013-05-20       Impact factor: 5.157

8.  Mobilization of a plant transposon by expression of the transposon-encoded anti-silencing factor.

Authors:  Yu Fu; Akira Kawabe; Mathilde Etcheverry; Tasuku Ito; Atsushi Toyoda; Asao Fujiyama; Vincent Colot; Yoshiaki Tarutani; Tetsuji Kakutani
Journal:  EMBO J       Date:  2013-07-30       Impact factor: 11.598

Review 9.  Dicer's role as an antiviral: still an enigma.

Authors:  Christopher R MacKay; Jennifer P Wang; Evelyn A Kurt-Jones
Journal:  Curr Opin Immunol       Date:  2013-11-22       Impact factor: 7.486

10.  Transgenic rice expressing rice stripe virus NS3 protein, a suppressor of RNA silencing, shows resistance to rice blast disease.

Authors:  Gentu Wu; Jiaoyu Wang; Yong Yang; Bo Dong; Yanli Wang; Guochang Sun; Chengqi Yan; Fei Yan; Jianping Chen
Journal:  Virus Genes       Date:  2014-02-21       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.